Outsourcing global clinical
& medical engagement for accelerated drug approval
& acceptance
AnswerY™, an AI-driven, HIPAA-compliant platform of prescriber-patient conversations that drives next-best actions
No image found.
This poster was originally presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conference 2024, held May 5–June 8, 2024, in Atlanta, GA.
Authors: David Iwanyckyj, Pablo Racana, Ashley Gamble, PhD, Melanie Jardim, PhD
Affiliations: Amplity, Langhorne, PA, USA
This study leveraged AnswerY™ (formerly known as Amplity Insights), our robust, HIPAA-compliant real-world database (RWD), composed of transcribed physician notes, to characterize the real-world clinical and humanistic burden of Alzheimer’s disease (AD).